Citation Impact
Citing Papers
Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial
2012 Standout
Molecular-phylogenetic characterization of microbial community imbalances in human inflammatory bowel diseases
2007 Standout
Mucosal healing in inflammatory bowel diseases: a systematic review
2012 Standout
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
2008 Standout
The gut microbiota and host health: a new clinical frontier
2015 Standout
Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment
2012 Standout
Transcriptional and epigenetic basis of Treg cell development and function: its genetic anomalies or variations in autoimmune diseases
2020 StandoutNobel
An Update on the Epidemiology of Inflammatory Bowel Disease in Asia
2008
Systemic and topical steroids in inflammatory bowel disease
2004
European evidence based consensus on the diagnosis and management of Crohn’s disease: current management
2006
Management of Crohn's disease in adults
2001
Review article: monitoring of immunomodulators in inflammatory bowel disease
2005
Increasing Incidence and Prevalence of the Inflammatory Bowel Diseases With Time, Based on Systematic Review
2011 Standout
Appendicectomy as a Therapy for Ulcerative Proctitis
2009
Risk factors for inflammatory bowel disease in the general population
2005
Ulcerative Colitis
2011 Standout
Burden of liver diseases in the world
2018 Standout
Unravelling the pathogenesis of inflammatory bowel disease
2007 StandoutNature
The risk of developing Crohn’s disease after an appendectomy: a population-based cohort study in Sweden and Denmark
2007
Challenges associated with identifying the environmental determinants of the inflammatory bowel diseases
2010
Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice
2004
Guidelines for the management of inflammatory bowel disease in adults
2011
Crohn's disease patients who quit smoking have a reduced risk of reoperation for recurrence
2004
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
2003 Standout
A cytokine-mediated link between innate immunity, inflammation, and cancer
2007 Standout
Clinical Experience With Infliximab Therapy in 100 Patients With Crohn's Disease
2000
Inflammatory bowel disease: clinical aspects and established and evolving therapies
2007 Standout
Comparative Tolerability of Treatments for Inflammatory Bowel Disease
2000
Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee
2004 Standout
Crohn's disease
2012 Standout
Protective role of appendicectomy on onset and severity of ulcerative colitis and Crohn’s disease
2002
Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases
2009
Association of antibody responses to microbial antigens and complications of small bowel Crohn’s disease
2004
Ulcerative colitis
2002
Efficacy of parenteral methotrexate in refractory Crohn’s disease
2001
The natural history of corticosteroid therapy for inflammatory bowel disease: A population-based study
2001 Standout
Inflammatory bowel disease: cause and immunobiology
2007 Standout
Appendectomy is followed by increased risk of Crohn's disease
2003
Inflammatory Bowel Disease
2009 Standout
Has disease outcome in Crohn's disease changed during the last four decades?
2004
Thiopurine-Induced Myelotoxicity in Patients With Inflammatory Bowel Disease: A Review
2008
Immunoglobulin G4–Associated Cholangitis: Clinical Profile and Response to Therapy
2008 Standout
Clinical Course of Distal Ulcerative Colitis in Relation to Appendiceal Orifice Inflammation Status
2005
Inflammatory Bowel Disease and Smoking
2004
Activation-Induced Cytidine Deaminase Links Between Inflammation and the Development of Colitis-Associated Colorectal Cancers
2008 StandoutNobel
Epidemiology of primary sclerosing cholangitis and primary biliary cirrhosis: A systematic review
2012
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
2006 Standout
Ulcerative colitis
2012 Standout
Medical management of left-sided ulcerative colitis and ulcerative proctitis: Critical evaluation of therapeutic trials
2006
Crohn's disease
2016 Standout
Acute appendicitis: modern understanding of pathogenesis, diagnosis, and management
2015 Standout
Inflammatory Bowel Disease
2002 Standout
Review article: remission rates achievable by current therapies for inflammatory bowel disease
2011
The Impact of the Gut Microbiota on Human Health: An Integrative View
2012 Standout
Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial
2002 Standout
High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn’s disease
2004 Standout
Recognition of Commensal Microflora by Toll-Like Receptors Is Required for Intestinal Homeostasis
2004 Standout
Second European evidence-based consensus on the diagnosis and management of ulcerative colitis Part 2: Current management
2012
Ulcerative colitis
2016 Standout
The Risk of Developing Crohn's Disease After an Appendectomy: A Meta-Analysis
2008
Pharmacokinetic Considerations in the Treatment of Inflammatory Bowel Disease
2001
The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management
2010
Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee
2010
Effectiveness of concomitant immunosuppressive therapy in suppressing the formation of antibodies to infliximab in Crohn’s disease
2007
MEDICAL THERAPY FOR INFLAMMATORY BOWEL DISEASE
1999
Genetics and pathogenesis of inflammatory bowel disease
2011 StandoutNature
The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications
2006 Standout
Azathioprine or methotrexate in the treatment of patients with steroid‐dependent or steroid‐resistant ulcerative colitis: results of an open‐label study on efficacy and tolerability in inducing and maintaining remission
2002
The epidemiology and natural history of primary biliary cirrhosis
2012
Role of Appendicitis and Appendectomy in the Pathogenesis of Ulcerative Colitis: A Critical Review
2002
Oral budesonide in the treatment of primary sclerosing cholangitis
2000
Role of genetic and environmental factors in British twins with inflammatory bowel disease
2011
Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences
2004 Standout
The Toronto Consensus Statements for the Management of Inflammatory Bowel Disease in Pregnancy
2015
Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies
2017 Standout
The Second European Evidenced-Based Consensus on Reproduction and Pregnancy in Inflammatory Bowel Disease
2014
Epidemiology and Natural History of Inflammatory Bowel Diseases
2011 Standout
Effects of Current Cigarette Smoking on Clinical Course of Crohn's Disease and Ulcerative Colitis
2001
Optimization of conventional therapy in patients with IBD
2011
Systematic review: the effectiveness of budesonide therapy for Crohn's disease
2002
Epidemiology of inflammatory bowel disease in a German twin cohort: Results of a nationwide study
2008
Diversity, stability and resilience of the human gut microbiota
2012 StandoutNature
Interferon β-1a in ulcerative colitis: a placebo controlled, randomised, dose escalating study
2003
Regulatory T Cell-Specific Epigenomic Region Variants Are a Key Determinant of Susceptibility to Common Autoimmune Diseases
2020 StandoutNobel
Environmental risk factors in inflammatory bowel diseases. Investigating the hygiene hypothesis: A Spanish case–control study
2010
Population-based case-control study of measles, mumps, and rubella and inflammatory bowel disease
2007
Azathioprine or 6-mercaptopurine for induction of remission in Crohn's disease
2010
Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease
2010 Standout
Immunosuppressive drugs in ulcerative colitis: twisting facts to suit theories?
2006
Effects of appendicectomy on the course of ulcerative colitis
2002
Medical therapy for ulcerative colitis
2000
Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease
2013 Standout
Glucocorticosteroid Therapy in Inflammatory Bowel Disease: Systematic Review and Meta-Analysis
2011
American Gastroenterological Association Institute Technical Review on Corticosteroids, Immunomodulators, and Infliximab in Inflammatory Bowel Disease
2006
Management of Crohn's Disease in Adults
2009 Standout
Cigarette smoking, appendectomy, and tonsillectomy as risk factors for the development of primary sclerosing cholangitis: a case control study
2002
A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease
2002
Passive Smoking and Inflammatory Bowel Disease: A Meta-Analysis
2008
Therapy of inflammatory bowel disease
2000
Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis
2005 Standout
An Evidence-Based Systematic Review on Medical Therapies for Inflammatory Bowel Disease
2011
Induction of clinical and colonoscopic remission of mild–to–moderate ulcerative colitis with budesonide MMX 9 mg: pooled analysis of two phase 3 studies
2015
Environmental risk factors for inflammatory bowel disease.
2010
Oral beclometasone dipropionate in the treatment of active ulcerative colitis: a double‐blind placebo‐controlled study
2002
Methotrexate for induction of remission in refractory Crohn's disease
2014
Methotrexate for maintenance of remission in ulcerative colitis
2015
Regulatory T Cells and Human Disease
2020 StandoutNobel
Methotrexate for maintenance of remission in Crohn's disease
2014
[American Gastroenterological Association Institute technical review on corticosteroids, immunomodulators, and infliximab in inflammatory bowel disease].
2007
Inflammatory Bowel Disease
2010 Standout
Oxidative Stress: An Essential Factor in the Pathogenesis of Gastrointestinal Mucosal Diseases
2014 Standout
A Diet Low in Red and Processed Meat Does Not Reduce Rate of Crohn’s Disease Flares
2019 Standout
Review article: integrating budesonide‐MMX into treatment algorithms for mild‐to‐moderate ulcerative colitis
2014
A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative Colitis
2006 Standout
Budesonide for induction of remission in Crohn's disease
2015
European evidence-based Consensus on the management of ulcerative colitis: Current management
2008
MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands
2010 StandoutNobel
Guidelines for the Management of Inflammatory Bowel Disease in Children in the United Kingdom
2010
Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease
2015
Works of Shmuel Odes being referenced
Methotrexate in chronic active Crohn's disease: a double-blind, randomized, Israeli multicenter trial.
1997
Maternal inflammatory bowel disease has short and long-term effects on the health of their offspring: A multicenter study in Israel
2012
Appendectomy is more frequent but not a risk factor in Crohn's disease while being protective in ulcerative colitis: a comparison of surgical procedures in inflammatory bowel disease
2001
Methotrexate in chronic active ulcerative colitis: A double-blind, randomized, Israeli multicenter trial
1996
Measles is more prevalent in Crohn's disease patients. A multicentre Israeli study
2001
Lack of Association Between Smoking and Crohn's Disease But The Usual Association With Ulcerative Colitis in Jewish Patients in Israel: A Multicenter Study
2000
Passive smoking in patients with inflammatory bowel disease
2000
The Month of Birth is Linked to the Risk of Crohn's Disease in the Israeli Population
2004
Disease outcome in an inception cohort of 595 patients in the European Collaborative Study on IBD
1998
Budesonide versus prednisone in the treatment of active Crohn's disease
1998
The epidemiology of primary biliary cirrhosis in southern Israel.
2005
Disease outcome in an inception cohort of 595 patients in the European Collaborative Study on IBD
1998